Atlas Trials

Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the Fate of the Patients with Good CAP Grade

Clinical trial NCT06630481 · COMPLETED

Trial details

NCT number
NCT06630481
Sponsor
Seoul National University Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Pancreatic CancerNeoadjuvant TherapyPathological Complete Response
Start date
2009-01-01
Primary completion
2023-12-31
Enrollment
462

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.